Research that is free to access for all investors. Companies commission these providers to write research about them.
Brokers who write research on their corporate clients and make it available through our main bundle offering.
Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.
Event in Progress:
Discover the latest content that has just been published on Research Tree
Following the management overhaul in June 2023, Dolfines has undergone a big restructuring to cut costs and overcome operational issues. The governance problems led to a 50% decline in Dolfines’ turnover while the other group companies delivered flat performances. Despite cancelled contracts in H1, the company has also signed new ones to support turnover over the next year. The cash position and debt level remain an issue of vital importance despite the improving operational strength.
Companies: Dolfines SA
AlphaValue
More dilution on the horizon to solve the cash problem TARGET CHANGE CHANGE IN TARGET PRICE € 0.00 vs 0.00 -61.8% The target price resets 62% lower having been negatively impacted by the massive dilution now accounted for in our model. We have increased the number of shares to 9.6 billion from 2.96 billion to reflect the dilutive repercussions of the equity funding the company needs and will have to carry out to prop up the balance sheet and solve the cash problem to be able to finance
Immeasurable dilution smashes valuation, once more TARGET CHANGE CHANGE IN TARGET PRICE € 0.00 vs 0.01 -65.8% In the aftermath of our latest update 2 weeks ago, Dolfines has completed another round of share issuance with 1.9bn new shares. While there have been no changes to our financial estimates given no new updates on the business front, the dilution has slashed the valuation and massively weighed on the target price. CHANGE IN NAV € 0.01 vs 0.03 -65.1% Given the significant n
Business growth embarked, but dilution kills the valuation TARGET CHANGE CHANGE IN EPS 2023 : € 0.00 vs 0.00 ns 2024 : € 0.00 vs 0.00 ns Our FY22 figures have been decreased with the integration of the annual results as the net attributable result was negatively impacted by exceptional financial expenses. CHANGE IN NAV € 0.03 vs 0.10 -71.5% Similarly, share dilution has reduced the NAV valuation by more than 70% despite a slight increase in the absolute net value of the assets t
After a long period of searching for another profitable acquisition, Dolfines decided to expand its footprint in the Health, Safety and Environment market and buy out AEGIDE International, which has more than 200 clients across the world. In FY22, the acquired company generated turnover of €2.75m, and had averaged 15% annual growth over the last three years. In our view, the acquisition enhances Dolfines’ opportunities and sheds some light on the future path of the company.
Dolfines has executed an equity financing programme to prop up its balance sheet and finance an acquisition in FY22. The result was a year-long downhill trend on the share price at a stupefying level of 98%. Committed to the strategy to generate more revenues and expand market share, Dolfines embarked on another cash-accretive acquisition opportunity this year, again with equity line financing that will sustain downward pressure on the stock for at least until the end of Q1.
TARGET CHANGE CHANGE IN TARGET PRICE € 0.06 vs 0.07 -21.6% The target price is reduced due to the declining DCF and NAV values. At such low prices, a slight change in the price brings about significant change. CHANGE IN NAV € 0.10 vs 0.14 -27.4% The NAV decrease stems from the massive dilution the company carried out in FY2022 with the number of shares increasing by more than 12x. The share issuance continued in early FY2023, further reducing the NAV. CHANGE IN DCF € 0.09 vs 0.12
Capital increase slashes the valuation TARGET CHANGE CHANGE IN NAV € 0.14 vs 0.27 -48.4% Since our last update, Dolfines has continued its capital increase programme with the conversion of the remaining bonds. The conversion of notes resulted in a massive dilution by creating more than 100 million shares (almost doubling), which was reflected in the tanking share price since September 2022. Accordingly, our NAV is severely impacted by the rising number of shares. CHANGE IN DCF € 0.12
Costly financing cuts the target price TARGET CHANGE CHANGE IN TARGET PRICE € 0.14 vs 0.40 -66.0% In the aftermath of last week's developments on equity line financing, we have updated our model. The massive dilution resulted in a 3x increase in the number of outstanding shares. We are expecting the financing woes to continue into next year, and have hence downgraded our target price. CHANGE IN EPS 2022 : € (0.01) vs (0.02) ns 2023 : € (0.01) vs (0.03) ns The dilution as a resul
In a recent round of equity line financing with convertible bonds, Dolfines was able to bring €4,135k to finance a new acquisition, pay debts and invest in research and development projects. But this came at a grave cost for the shareholders as the share price nose-dived. At this point, the company and the shareholders could only hope for this precarious form of financing to do its job and facilitate cash generation from investments.
Revenue stood at €4.3m in H1, confirming the positive momentum communicated in Q1. The Oil & Gas activities recovered sharply with the high oil price, while the strong growth continued at 8.2 France. The prospects also look good for H2, with drilling activity remaining elevated and with the workforce growing in Renewable energies. Overall, a positive update, which will help to support the stock price.
The strategy update was in line with the recent communications from the company, but provided more details ahead of the capital increase. While the oil & gas activities continue to recover, the priority remains on renewables (both inorganic and organic). A large share of the proceeds will fund acquisitions, with one soon to be announced in renewables services. Furthermore, the company is aiming to break-even at operating cash flow level by the end of the year.
TARGET CHANGE CHANGE IN EPS 2022 : € (0.02) vs (0.02) ns 2023 : € (0.03) vs (0.03) ns We have updated our model with the integration of the FY21 results and net loss of €1.55m. Estimates for FY22/FY23 are unchanged. CHANGE IN NAV € 0.83 vs 1.01 -17.0% Following the FY21 results, we have added a €4m capital increase, at a subscription price of €0.30 per share, leading to the creation of 13.3m shares. This represents a c. 30% discount on the 29/04/2022 closing price (day of the annou
The FY21 results came in below our expectations as Covid-19 dragged on mobility thus limiting oil & gas activities, although the strong start to the year confirms that the recovery is ongoing. As investments ramp up, the company has announced a c. €4m recap, split between debt conversion and an equity increase. The latter should be enough to sustain research & development activities in renewables for both the new floater and the telescopic arm for offshore wind inspection.
EPS CHANGE CHANGE IN EPS 2021 : € (0.06) vs (0.06) ns 2022 : € (0.02) vs (0.03) ns The company has published a positive release, with a strong January and February in inspection and audit (Factorig). We are thus slightly increasing our estimates for Factorig, to €3m of revenue for FY22 vs €2.5m previously, partly offset by lower estimates in Services, where we now forecast revenue of €1.5m vs €1.7m previously.
Research Tree provides access to ongoing research coverage, media content and regulatory news on Dolfines SA. We currently have 50 research reports from 1 professional analysts.
Companies: AYM EUA TYM BEM AAU BZT HOC KAV COBR RMR SVML GEMD
SP Angel
Companies: TYM BEM ALBA SML ATM MKA
Companies: BSE JLP AAZ BZT HUM POW 2899 BHP GROC EDV
Companies: RSG S32 GAL KAV SRB MKA GEMD
Companies: Synergia Energy Ltd
Panmure Liberum
Companies: Gulf Keystone Petroleum Limited
Canaccord Genuity
Companies: Intercede Group plc (IGP:LON)Cornish Metals Inc. (CUSN:LON)
Cavendish
The Office for National Statistics (ONS) is due to publish its most up-to-date survey on share ownership in mid-January, which identifies the beneficial owners and decision- makers of the stock market. Hardman & Co has worked together with the share analysis service, Argus Vickers, to jointly produce its own survey, which anticipates the conclusions of the ONS survey but goes into much greater detail. Our work does not use a sample of 200 quoted companies as the ONS historically has, but rather
Companies: CMH SCE ARBB AGY RECI CLIG GDR PCA RMII PHP SHED VTA BUR PIN
Hardman & Co
Jubilee today announces that it has signed a 3-year renewable power agreement with Lunsemfwa Hydro Power Co (LHPC). The agreement will provide all of the power needs for the Sable copper refinery and the Roan concentrator with an additional agreement that Jubilee can purchase a further 10MW of solar power to provide electricity as it expands its operational footprint in Zambia. We see this as a great deal for Jubilee as it secures power and reduces any outages (providing both extra security and
Companies: Jubilee Metals Group PLC
Zeus Capital
Beowulf is an AIM/Spotlight-listed developer of two flagship assets; Kallak, a high-grade iron ore project in Sweden and the Grafintec Graphite Anode Materials Plant. The Company's Kallak North project has the potential to produce 2.5mtpa of high-grade, premium iron ore concentrate suitable for the growing green steel industry in Sweden. Additionally, Grafintec's Anode Material Plant Project is well positioned to serve the growing EV battery supply chain in Europe, whilst supporting EU plans
Companies: Beowulf Mining PLC
i3 Energy* (I3E LN) - Energy Flash Note - 2H24 capex programme to restore growth
Companies: i3 Energy Plc
21 February 2023 @HybridanLLP Status of this Note and Disclaimer This document has been issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objec
Companies: SLP AXL BGO ZOO VRS SPR
Hybridan
28th April 2023 @HybridanLLP Status of this Note and Disclaimer This document has been issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment object
Companies: TGIF BEM WYN ZOO SDX TM17 GDLF
14th July 2023 @HybridanLLP Status of this Note and Disclaimer This document has been issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objecti
Companies: ONEM JSG ZOO HUW SML SAV VRS
Companies: PCIP SNG TIME LBE MPL DUKE